Products Cinnarizine is commercially available in the form of capsules, tablets, and drops (Stugeron, generic). It has been approved in many countries since 1968. Since 2012, a fixed combination with dimenhydrinate has been on the market in many countries (Arlevert) see under Cinnarizine and Dimenhydrinate. Structure and properties Cinnarizine (C26H28N2, Mr = 368.51 g/mol) exists … Cinnarizine Effects and Side Effects
Products Ciprofloxacin is commercially available as film-coated tablets, oral suspension, infusion preparation, eye drops, eye ointment (Ciloxan), and ear drops (Ciproxin HC + hydrocortisone). In addition to the original Ciproxin, various generics are available. Ciprofloxacin was approved in many countries in 1987. This article refers to peroral administration. Structure and Properties Ciprofloxacin (C17H18FN3O3, Mr = … Ciprofloxacin
Products Bosutinib is commercially available in the form of film-coated tablets (Bosulif). The drug was approved in many countries in 2014. Structure and properties Bosutinib (C26H29Cl2N5O3, Mr = 530.4 g/mol) is a quinoline and piperazine derivative. It is present in drugs as bosutinib monohydrate, a white to yellowish powder that is sparingly soluble in water. … Bosutinib
Products Cetirizine is commercially available as film-coated tablets, lozenges, and drops (Zyrtec, generic). It has been approved in many countries since 1989. Structure and properties Cetirizine (C21H25ClN2O3, Mr = 388.9 g/mol) is a racemate consisting of –levocetirizine and -dextrocetirizine. It is present in drugs as cetirizine dihydrochloride, a white powder that is readily soluble in … Cetirizine Effects and Side Effects
Products Vortioxetine is commercially available as film-coated tablets and as an oral solution (drops). It was approved in the United States and the EU in 2013 and in many countries in 2016 (Brintellix, United States: Trintellix). Structure and properties Vortioxetine (C18H22N2S, Mr = 298.4 g/mol) is a piperazine derivative. It is present in the film-coated … Vortioxetine
Products Levocetirizine is commercially available in the form of film-coated tablets and as drops (Xyzal, generic). It has been approved in many countries since 2001. Levocetirizine is the -enantiomer of cetirizine (Zyrtec, both UCB-Pharma SA). Levocetirizine tablets contain 5 mg of active ingredient; cetirizine tablets contain 10 mg (plus 5 mg of the -enantiomer). Unlike … Levocetirizine
Products Ranolazine is commercially available in the form of sustained-release tablets (Ranexa). It was approved in the United States as early as 2006, in the EU in July 2008, and in many countries in April 2010. Structure and properties Ranolazine or ()–(2, 6-dimethylphenyl)-4(2-hydroxy-3-(2-methoxyphenoxy)-propyl)-1-piperazine acetamide (C24H33N3O4, Mr = 427.54 g/mol) is a piperazine derivative and a … Ranolazine
Products Hydroxyzine is commercially available in the form of film-coated tablets and as a syrup (Atarax). It has been approved in many countries since 1956. Structure and properties Hydroxyzine (C21H27ClN2O2, Mr = 374.9 g/mol) is a piperazine derivative. It is present in drugs as hydroxyzine hydrochloride, a white crystalline powder that is readily soluble in … Hydroxyzine
